Furthermore, peptide vaccination against GPNMB eliminated GPNMB-positive senescent cells, reducing atherosclerotic plaque burden and metabolic dysfunction such as glucose intolerance in mouse models of obesity and atherosclerosis [125]. This evidence concerns the gene GPNMB and obesity disorder.